The Blood Bags Market is estimated to be valued at USD 500.0 million in 2025 and is projected to reach USD 956.4 million by 2035, registering a compound annual growth rate (CAGR) of 6.7% over the forecast period.
| Metric | Value |
|---|---|
| Blood Bags Market Estimated Value in (2025 E) | USD 500.0 million |
| Blood Bags Market Forecast Value in (2035 F) | USD 956.4 million |
| Forecast CAGR (2025 to 2035) | 6.7% |
The blood bags market is experiencing consistent growth driven by increasing demand for safe blood collection, storage, and transfusion practices across healthcare systems. Rising incidences of trauma cases, surgeries, and chronic diseases requiring regular blood transfusion are supporting the use of advanced blood storage solutions.
Governments and healthcare organizations are emphasizing stringent safety protocols, sterile collection methods, and efficient storage capacity, which are contributing to the widespread adoption of standardized blood bags. Technological improvements in materials and labeling have enhanced product safety and traceability.
Furthermore, the growing network of blood donation drives and awareness programs is reinforcing demand for high quality blood collection and storage products. The overall market outlook remains positive as hospitals and blood banks continue to invest in reliable transfusion infrastructure and improved blood management systems.
The single blood bag product type is expected to hold 47.60% of market revenue by 2025, making it the most prominent product type segment. Its dominance is attributed to cost effectiveness, ease of use, and wide availability across both developed and developing healthcare systems.
Single blood bags are preferred in routine transfusion and collection processes where separation of components is not required. Their adoption has been reinforced by high frequency blood donation programs and increased usage in general hospital settings.
Their affordability and operational efficiency continue to strengthen their position as the leading product type in the blood bags market.
The less than 250 ml capacity segment is projected to account for 42.90% of market revenue by 2025, positioning it as the leading capacity type. This growth is supported by rising demand for pediatric transfusions, neonatal care, and cases requiring precise low volume collection.
Hospitals and specialized care centers frequently adopt this size due to safety and accuracy in dosing. The segment is also reinforced by ongoing pediatric health programs and blood donation initiatives targeted toward younger populations.
The ability to support small volume collection without compromising on sterility or storage stability has positioned this capacity as a preferred option across healthcare facilities.
The global blood bags market registered a CAGR of 6.4% during the historic period with a market value of USD 500 million in 2025. This growth can be attributed to several factors, including the increasing demand for blood and blood products, the rise in the number of blood donations, and the growing prevalence of chronic diseases such as cancer and haemophilia.
Blood components like red blood cells (RBCs), white blood cells (WBCs), and blood platelets are transported and stored in blood bags. The blood bags must be used to store both the blood and its constituent parts. The blood is extremely sensitive to changes in temperature, light, and air, blood bags are required to retain blood and its constituent parts.
For the collection, storage, and transportation of blood and its constituent parts, blood bags have taken the position of glass bottles. The blood bags are designed in a way that makes it simple to separate the various components of the blood that has been collected. Accidents are happening more frequently, which is driving up demand for blood bags.
In addition, technological advancements in the manufacturing of blood bags, such as the use of PVC-free materials and improved sterilization techniques, are also contributing to the blood bags market growth.
The market is also facing challenges such as the high cost of blood bags and stringent regulations for their manufacturing and distribution. The COVID-19 pandemic had a moderate impact on the market, with disruptions in the supply chain and reduced blood donations in some regions. Overall, the blood bags market is expected to continue to grow, driven by increasing demand and advancements in technology.
The rising awareness about blood donation is a significant driver for the growth of the blood bags market. As more people become aware of the importance of blood donation, there is an increase in the number of blood donations.
This leads to a higher demand for blood bags. Blood bags are essential for the collection, storage, and transportation of blood and blood components. With more people donating blood, there is a need for an adequate supply of blood bags to ensure that the collected blood is safe and can be used for transfusion when needed.
Moreover, the increasing awareness of the need for safe and high-quality blood transport is driving the demand for blood bags that are manufactured to high standards and quality. This, in turn, is leading to the adoption of advanced blood bag technologies that improve the safety, reliability, and durability of blood bags.
Blood bags are used in a wide range of healthcare applications, including blood transfusions, blood component therapy, and blood collection for testing and analysis. As the healthcare sector expands, the demand for these applications also increases, driving the need for more blood bags.
In addition, the growth of the healthcare sector is also leading to advancements in blood bag technologies, such as the use of PVC-free materials and improved sterilization techniques. These advancements are improving the safety and quality of blood bags, leading to better patient outcomes and driving the demand for more advanced blood bag technologies.
Overall, the growing healthcare sector is a significant driver for the blood bags market, as it increases the demand for blood bags and supports the adoption of advanced blood bag technologies.
The triple blood bags is expected to experience the consistent demand in the market during the forecast period. The same segment is projected to grow 1.7 times the current market value during the forecast period.
These bags are used for collection, preservation, and transfusion of Packed Red Blood Cells (PRBC) Platelets (PLT) and Plasma (FFP). The surge in need for separating blood into three components fuel the demand for triple blood bags.
The leading end user in the blood bags market is the hospitals segment followed by blood banks segment. Hospitals and blood banks are the primary facilities where blood bags are used for blood collection, storage, and transfusion.
Hospitals use blood bags for a wide range of medical procedures, including surgeries, trauma cases, and critical care treatments, where blood transfusions may be necessary. Blood banks collect and store blood and blood components for use in emergencies and medical treatments.
The growing demand for blood bags in hospitals and blood banks is driven by the increasing prevalence of chronic diseases, growing aging population, rising number of surgeries, and trauma cases.
The COVID-19 pandemic has also increased the demand for blood bags in hospitals as many patients required blood transfusions during their treatment. Both the segment collectively are estimated to hold nearly 61% of the market value share by the end of 2025.
| Countries | USA |
|---|---|
| Market Share (2025) | 28.3% |
| Market Share (2035) | 25.7% |
| BPS Analysis | -300 |
| Countries | China |
|---|---|
| Market Share (2025) | 9.2% |
| Market Share (2035) | 11.0% |
| BPS Analysis | +220 |
| Countries | Germany |
|---|---|
| Market Share (2025) | 6.7% |
| Market Share (2035) | 5.2% |
| BPS Analysis | -100 |
| Countries | UNITED KINGDOM |
|---|---|
| Market Share (2025) | 5.3% |
| Market Share (2035) | 5.7% |
| BPS Analysis | +30 |
| Countries | Canada |
|---|---|
| Market Share (2025) | 4.4% |
| Market Share (2035) | 6.1% |
| BPS Analysis | +140 |
The USA is projected to hold around 84% of the market value share by the end of 2025. The USA has advanced medical infrastructure, technological innovations in blood collection and storage, strong regulatory standards. Also, the presence of major pharmaceutical companies that invest heavily in the development of blood-related products.
The USA has a large population and a robust healthcare system that demands a high volume of blood and blood-related products. According to the American National Red Cross, in February 2024, approximately 29,000 units of red blood cells were required daily and that nearly 21 million blood components were transfused in the USA This factor fuel the demand for blood bags.
India's road traffic accidents have been surging in recent years, leading to an increase in demand for blood in the country. This is because many of the accident victims require blood transfusions as a part of their treatment, and the demand for blood bags increases accordingly.
According to Government of India ministry of road transport and highways transport, during the year 2024, a total number of 4,12,432 road accidents have been reported in the country, claiming 1,53,972 lives and causing injuries to 3,84,448 persons.
People suffer non-fatal injuries, and many of them develop disabilities as a result. As a result, the growth of the blood bags market is closely tied to the incidence of road traffic accidents in India. India blood bags market is anticipated to register a CAGR of XX% during 2025 to 2035.
The major players in the market are gaining market value by developing new innovations and advancement in the blood bags market. Recent activities and mergers implemented by the leading player in the market are:
| Attribute | Details |
|---|---|
| Growth Rate | CAGR of 6.7% from 2025 to 2035 |
| Base Year for Estimation | 2025 |
| Historical Data | 2020 to 2025 |
| Forecast Period | 2025 to 2035 |
| Quantitative Units | Revenue in USD million, Volume in Units and CAGR from 2025 to 2035 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered | Product Type, Capacity, End User, Region |
| Regions Covered | North America; Latin America; East Asia; South Asia & Pacific; Western Europe; Eastern Europe; Central Asia; Russia & Belarus; Balkan Countries; Baltic Countries; Middle East & Africa |
| Key Countries Covered | USA, Canada, Mexico, Brazil, Germany, UNITED KINGDOM, France, Italy, Spain, Russia, China, Japan, India, GCC countries, Australia & New Zealand |
| Key Companies Profiled | Haemonetics Corporation; Terumo Blood and Cell Technologies; Macopharma USA; Fresnuise Kabi India Pvt., Ltd; Qingdao Sinoland International Trade Co.; Genesis BPS, BL Lifesciences; Mitra Industries Pvt. Ltd.; Suru International Pvt. Ltd.; B. Braun Melsungen AG (Germany); HLL Lifecare Limited; Wego Group; Polymedicure Limited; Kawasumi Laboratories Inc.; GVS S.p.A.; VOGT Medical Ltd.; Advin Health Care; QED Kares Pvt. Ltd.; Terumo Pepnol Pvt. Ltd.; JMS North America Corporation; AdvaCare Pharma; Ishwari Health Care Pvt. Ltd.; Imperial Biotech Pvt. Ltd.; Lmb Technologies GmbH; Vardha Health Care; PVC Med Alliance; Marg Pharma Ltd.; Narang Medical Limited; Suru International Pvt. Ltd.; BMS Group; Kansuk ilaç |
| Customization & Pricing | Available upon Request |
The global blood bags market is estimated to be valued at USD 500.0 million in 2025.
The market size for the blood bags market is projected to reach USD 956.4 million by 2035.
The blood bags market is expected to grow at a 6.7% CAGR between 2025 and 2035.
The key product types in blood bags market are single blood bag, double blood bag, triple blood bag, quadruple blood bag and penta blood bag.
In terms of capacity, less than 250 ml segment to command 42.9% share in the blood bags market in 2025.
Explore Similar Insights
Blood Bags Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
Chat With
MaRIA
